These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1883514)

  • 1. Lipopolysaccharide-instructed, cryopreserved, human monocytes sequentially convert plasma fibrinogen to fibrin and lyse the fibrin formed.
    Kierulf P; Andersen AB
    Pathobiology; 1991; 59(3):197-9. PubMed ID: 1883514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procoagulant and profibrinolytic activities of cryopreserved human monocytes.
    Osnes LT; Westvik AB; Kierulf P
    Thromb Res; 1994 Nov; 76(4):373-83. PubMed ID: 7871496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase.
    Schwartz BS; Levy GA; Fair DS; Edgington TS
    J Exp Med; 1982 May; 155(5):1464-79. PubMed ID: 7200121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fluctuations in pulmonary fibrin decomposing activities (plasmin and non-plasmin activities) in an endotoxin DIC model in rats].
    Okamoto U; Sasaki K; Nagao N; Naiki I; Nagamatsu Y
    Nihon Seirigaku Zasshi; 1982; 44(11):633-41. PubMed ID: 6221092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procoagulant activity of rabbit alveolar macrophages.
    Sitrin RG; Kaltreider HB; Ansfield MJ; Webster RO
    Am Rev Respir Dis; 1983 Aug; 128(2):282-7. PubMed ID: 6349442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
    J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide.
    Pretorius E; Mbotwe S; Bester J; Robinson CJ; Kell DB
    J R Soc Interface; 2016 Sep; 13(122):. PubMed ID: 27605168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
    Grinenko TV; Tret'iachenko VG; Kudinov SA; Medved' LV
    Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of chromogenic substrates in the study of blood coagulation and fibrinolysis].
    Rutllant ML
    Sangre (Barc); 1978; 23(6):858-63. PubMed ID: 311079
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and fibrin interaction with concanavalin A dimer and its influence on coagulation.
    Díaz-Mauriño T; Blanco R; Albert A
    Biochim Biophys Acta; 1984 May; 799(1):45-50. PubMed ID: 6722179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
    Lenfors S; Gustafsson D
    Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.